{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:34:27Z","timestamp":1790735667582,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA160578"],"award-info":[{"award-number":["CA160578"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.celrep.2021.109410","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:20:37Z","timestamp":1626873637000},"page":"109410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy"],"prefix":"10.1016","volume":"36","author":[{"given":"Christopher J.","family":"Terranova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayinuer","family":"Maitituoheti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush T.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archit K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir B.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Orouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Tomczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmistha","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Oba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Creasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Jiun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Lazcano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalida","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Barrodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Haydu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantale","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.109410_bib1","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1242\/dev.124.16.3077","article-title":"Early- and late-migrating cranial neural crest cell populations have equivalent developmental potential in\u00a0vivo","volume":"124","author":"Baker","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.celrep.2021.109410_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2014.06.027","article-title":"H3K4me3 breadth is linked to cell identity and transcriptional consistency","volume":"158","author":"Benayoun","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/CJI.0b013e31819c8bda","article-title":"Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients","volume":"32","author":"Besser","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.celrep.2021.109410_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1758834017708160","article-title":"Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date","volume":"9","author":"Boespflug","year":"2017","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.celrep.2021.109410_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2021.109410_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","article-title":"A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma","volume":"24","author":"Caramel","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"Chaffer","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ng.3385","article-title":"Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes","volume":"47","author":"Chen","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2021.109410_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13059-015-0594-4","article-title":"Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma","volume":"16","author":"Cheng","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2021.109410_bib14","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2021.109410_bib15","doi-asserted-by":"crossref","first-page":"eaav1898","DOI":"10.1126\/science.aav1898","article-title":"The chromatin accessibility landscape of primary human cancers","volume":"362","author":"Corces","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109410_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature19360","article-title":"Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition","volume":"537","author":"Dahl","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/hdy.2010.49","article-title":"Epigenetic regulation of development by histone lysine methylation","volume":"105","author":"Dambacher","year":"2010","journal-title":"Heredity"},{"key":"10.1016\/j.celrep.2021.109410_bib18","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/cdd.2014.44","article-title":"Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression","volume":"21","author":"Denecker","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2021.109410_bib19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1755-148X.2011.00873.x","article-title":"Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma","volume":"24","author":"Devitt","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.celrep.2021.109410_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2018.04.028","article-title":"MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes","volume":"70","author":"Dhar","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib21","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1158\/1078-0432.CCR-15-2226","article-title":"Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma","volume":"22","author":"Ekmekcioglu","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2021.109410_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nmeth.1906","article-title":"ChromHMM: automating chromatin-state discovery and characterization","volume":"9","author":"Ernst","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2021.109410_bib24","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","article-title":"SAMBLASTER: fast duplicate marking and structural variant read extraction","volume":"30","author":"Faust","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2021.109410_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.celrep.2017.03.078","article-title":"Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression","volume":"19","author":"Fiziev","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2021.109410_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib27","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1101\/gad.14.14.1712","article-title":"Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage","volume":"14","author":"Goding","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2021.109410_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-020-0818-7","article-title":"H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade","volume":"12","author":"Hoffmann","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.celrep.2021.109410_bib30","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1158\/1078-0432.CCR-17-0146","article-title":"Epigenetic Regulation of KPC1\u00a0Ubiquitin Ligase Affects the NF-\u03baB Pathway in Melanoma","volume":"23","author":"Iida","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2021.109410_bib31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cell.2016.04.031","article-title":"Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells","volume":"165","author":"Jadhav","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib32","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.celrep.2021.109410_bib33","doi-asserted-by":"crossref","first-page":"rs2","DOI":"10.1126\/scisignal.2005966","article-title":"An analysis of critical factors for quantitative immunoblotting","volume":"8","author":"Janes","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2021.109410_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11864-013-0226-8","article-title":"Update on the targeted therapy of melanoma","volume":"14","author":"Johnson","year":"2013","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.celrep.2021.109410_bib35","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2021.109410_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature09590","article-title":"The histone variant macroH2A suppresses melanoma progression through regulation of CDK8","volume":"468","author":"Kapoor","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib37","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/0008-5472.CAN-14-1174","article-title":"Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy","volume":"74","author":"Kemper","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.109410_bib38","doi-asserted-by":"crossref","first-page":"e1000242","DOI":"10.1371\/journal.pgen.1000242","article-title":"Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains","volume":"4","author":"Ku","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2021.109410_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13059-015-0617-1","article-title":"CopywriteR: DNA copy number detection from off-target sequence data","volume":"16","author":"Kuilman","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2021.109410_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14248","article-title":"Integrative analysis of 111 reference human epigenomes","volume":"518","author":"Kundaje","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib41","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2021.109410_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2004.05708.x","article-title":"Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma","volume":"150","author":"Lens","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.celrep.2021.109410_bib43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.celrep.2021.109410_bib44","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2021.109410_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fonc.2015.00031","article-title":"Phenotype switching in melanoma: implications for progression and therapy","volume":"5","author":"Li","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2021.109410_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature16546","article-title":"Active medulloblastoma enhancers reveal subgroup-specific cellular origins","volume":"530","author":"Lin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib47","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/gb-2011-12-8-r83","article-title":"Cistrome: an integrative platform for transcriptional regulation studies","volume":"12","author":"Liu","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2021.109410_bib48","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/s41467-018-04383-6","article-title":"Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes","volume":"9","author":"Lomberk","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109410_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109410_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.109410_bib51","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2021.109410_bib52","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/bioinformatics\/bts277","article-title":"BEDOPS: high-performance genomic feature operations","volume":"28","author":"Neph","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2021.109410_bib53","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib54","article-title":"Targeting the HGF\/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma","volume":"2018","author":"Oba","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.celrep.2021.109410_bib55","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.109410_bib56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1158\/2326-6066.CIR-17-0051","article-title":"SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity","volume":"5","author":"Park","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2021.109410_bib57","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2021.109410_bib58","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/2159-8290.CD-15-0493","article-title":"Dual Roles of RNF2 in Melanoma Progression","volume":"5","author":"Rai","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2021.109410_bib59","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2021.109410_bib60","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1038\/jid.2013.197","article-title":"Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis","volume":"133","author":"Raskin","year":"2013","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.celrep.2021.109410_bib61","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2017.07.007","article-title":"Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis","volume":"170","author":"Roe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109410_bib62","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2021.109410_bib63","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1242\/jcs.01328","article-title":"Dynamic alterations of specific histone modifications during early murine development","volume":"117","author":"Sarmento","year":"2004","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.celrep.2021.109410_bib64","doi-asserted-by":"crossref","first-page":"e1006636","DOI":"10.1371\/journal.pgen.1006636","article-title":"TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF","volume":"13","author":"Seberg","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2021.109410_bib65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/1471-2164-15-284","article-title":"ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases","volume":"15","author":"Shen","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.celrep.2021.109410_bib66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41598-017-01000-2","article-title":"Indicators of responsiveness to immune checkpoint inhibitors","volume":"7","author":"Shields","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2021.109410_bib67","doi-asserted-by":"crossref","first-page":"10909","DOI":"10.1038\/s41598-017-11366-y","article-title":"MITF and BRN2 contribute to metastatic growth after dissemination of melanoma","volume":"7","author":"Simmons","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2021.109410_bib68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Simon","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.celrep.2021.109410_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-018-0773-5","article-title":"Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype","volume":"17","author":"Sinnberg","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2021.109410_bib70","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109410_bib71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.109410_bib72","first-page":"56972","article-title":"An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues","volume":"134","author":"Terranova","year":"2018","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.celrep.2021.109410_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ydbio.2011.12.041","article-title":"Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration","volume":"366","author":"Theveneau","year":"2012","journal-title":"Dev. Biol."},{"key":"10.1016\/j.celrep.2021.109410_bib74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1476-4598-13-45","article-title":"MEK targeting in N-RAS mutated metastatic melanoma","volume":"13","author":"Thumar","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2021.109410_bib75","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: from mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2021.109410_bib76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2217\/epi.15.1","article-title":"Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders","volume":"7","author":"Vallianatos","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.celrep.2021.109410_bib77","doi-asserted-by":"crossref","first-page":"e1073417","DOI":"10.1080\/23723556.2015.1073417","article-title":"Histone variant H2A.Z.2: A novel driver of melanoma progression","volume":"3","author":"Vardabasso","year":"2015","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.celrep.2021.109410_bib78","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/ml3003346","article-title":"Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2","volume":"3","author":"Verma","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.celrep.2021.109410_bib79","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1101\/gad.219626.113","article-title":"A double take on bivalent promoters","volume":"27","author":"Voigt","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2021.109410_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI69740","article-title":"Characterizing DNA methylation alterations from The Cancer Genome Atlas","volume":"124","author":"Weisenberger","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2021.109410_bib81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2021.109410_bib82","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2021.109410_bib83","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/ncomms7051","article-title":"The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors","volume":"6","author":"Zingg","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109410_bib84","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.celrep.2017.07.007","article-title":"The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy","volume":"20","author":"Zingg","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2021.109410_bib85","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1755-148X.2010.00823.x","article-title":"A proliferative melanoma cell phenotype is responsive to RAF\/MEK inhibition independent of BRAF mutation status","volume":"24","author":"Zipser","year":"2011","journal-title":"Pigment Cell Melanoma Res."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721008238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721008238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:23:31Z","timestamp":1761909811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124721008238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2211124721008238"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.109410","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.109410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109410"}}